Paul Knight
Stock Analyst at Keybanc
(1.84)
# 3,176
Out of 5,182 analysts
141
Total ratings
44.44%
Success rate
-2.62%
Average return
Main Sectors:
Stocks Rated by Paul Knight
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| XGN Exagen | Maintains: Overweight | $15 → $10 | $2.74 | +264.96% | 8 | Mar 11, 2026 | |
| STVN Stevanato Group | Maintains: Overweight | $37 → $32 | $16.18 | +97.78% | 6 | Mar 5, 2026 | |
| TMO Thermo Fisher Scientific | Upgrades: Overweight | $750 | $468.04 | +60.24% | 7 | Dec 8, 2025 | |
| WST West Pharmaceutical Services | Maintains: Overweight | $325 → $350 | $302.20 | +15.82% | 12 | Oct 24, 2025 | |
| LFCR Lifecore Biomedical | Initiates: Sector Weight | n/a | $5.08 | - | 1 | Sep 4, 2025 | |
| ATR AptarGroup | Initiates: Overweight | $220 | $124.73 | +76.38% | 1 | Sep 4, 2025 | |
| CYRX Cryoport | Upgrades: Overweight | $15 | $10.38 | +44.51% | 9 | Aug 6, 2025 | |
| HBIO Harvard Bioscience | Downgrades: Sector Weight | n/a | $6.90 | - | 5 | Apr 9, 2025 | |
| TECH Bio-Techne | Downgrades: Sector Weight | n/a | $55.11 | - | 9 | Apr 9, 2025 | |
| WAT Waters | Upgrades: Overweight | $460 | $299.79 | +53.44% | 5 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $0.90 | - | 2 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $8 | $2.36 | +238.98% | 1 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $132 → $145 | $86.80 | +67.05% | 3 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $400 → $420 | $146.94 | +185.83% | 1 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $213 → $230 | $106.77 | +115.42% | 1 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $33 | $21.41 | +54.13% | 5 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $28 → $36 | $24.98 | +44.12% | 7 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $290 → $310 | $180.62 | +71.63% | 9 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $210 → $220 | $118.29 | +85.98% | 7 | Feb 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $3.68 | - | 8 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $3.14 | - | 1 | Jul 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $115.62 | - | 8 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $25.15 | - | 3 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $51 → $40 | $7.97 | +401.88% | 6 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $390 → $300 | $171.23 | +75.20% | 1 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $290 → $250 | $163.84 | +52.59% | 1 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $382 → $441 | $135.07 | +226.50% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $222 → $236 | $122.85 | +92.10% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $92 → $99 | $64.34 | +53.87% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $47 → $55 | $24.62 | +123.40% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $33.85 | - | 4 | Nov 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $98.28 | - | 1 | Nov 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $128.52 | - | 5 | Oct 23, 2017 |
Exagen
Mar 11, 2026
Maintains: Overweight
Price Target: $15 → $10
Current: $2.74
Upside: +264.96%
Stevanato Group
Mar 5, 2026
Maintains: Overweight
Price Target: $37 → $32
Current: $16.18
Upside: +97.78%
Thermo Fisher Scientific
Dec 8, 2025
Upgrades: Overweight
Price Target: $750
Current: $468.04
Upside: +60.24%
West Pharmaceutical Services
Oct 24, 2025
Maintains: Overweight
Price Target: $325 → $350
Current: $302.20
Upside: +15.82%
Lifecore Biomedical
Sep 4, 2025
Initiates: Sector Weight
Price Target: n/a
Current: $5.08
Upside: -
AptarGroup
Sep 4, 2025
Initiates: Overweight
Price Target: $220
Current: $124.73
Upside: +76.38%
Cryoport
Aug 6, 2025
Upgrades: Overweight
Price Target: $15
Current: $10.38
Upside: +44.51%
Harvard Bioscience
Apr 9, 2025
Downgrades: Sector Weight
Price Target: n/a
Current: $6.90
Upside: -
Bio-Techne
Apr 9, 2025
Downgrades: Sector Weight
Price Target: n/a
Current: $55.11
Upside: -
Waters
Mar 31, 2025
Upgrades: Overweight
Price Target: $460
Current: $299.79
Upside: +53.44%
Feb 27, 2025
Downgrades: Sector Weight
Price Target: n/a
Current: $0.90
Upside: -
Feb 12, 2025
Initiates: Overweight
Price Target: $8
Current: $2.36
Upside: +238.98%
Feb 3, 2025
Maintains: Overweight
Price Target: $132 → $145
Current: $86.80
Upside: +67.05%
Jan 23, 2025
Maintains: Overweight
Price Target: $400 → $420
Current: $146.94
Upside: +185.83%
Jan 23, 2025
Maintains: Overweight
Price Target: $213 → $230
Current: $106.77
Upside: +115.42%
Dec 13, 2024
Maintains: Overweight
Price Target: $30 → $33
Current: $21.41
Upside: +54.13%
Nov 5, 2024
Maintains: Overweight
Price Target: $28 → $36
Current: $24.98
Upside: +44.12%
Oct 23, 2024
Maintains: Overweight
Price Target: $290 → $310
Current: $180.62
Upside: +71.63%
Feb 15, 2024
Maintains: Overweight
Price Target: $210 → $220
Current: $118.29
Upside: +85.98%
Aug 8, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $3.68
Upside: -
Jul 12, 2023
Initiates: Sector Weight
Price Target: n/a
Current: $3.14
Upside: -
May 24, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $115.62
Upside: -
May 10, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $25.15
Upside: -
Sep 15, 2022
Maintains: Overweight
Price Target: $51 → $40
Current: $7.97
Upside: +401.88%
May 5, 2022
Maintains: Overweight
Price Target: $390 → $300
Current: $171.23
Upside: +75.20%
Apr 28, 2022
Maintains: Overweight
Price Target: $290 → $250
Current: $163.84
Upside: +52.59%
Jan 8, 2021
Maintains: Overweight
Price Target: $382 → $441
Current: $135.07
Upside: +226.50%
Jan 8, 2021
Maintains: Overweight
Price Target: $222 → $236
Current: $122.85
Upside: +92.10%
Jan 8, 2021
Maintains: Overweight
Price Target: $92 → $99
Current: $64.34
Upside: +53.87%
Jan 8, 2021
Maintains: Overweight
Price Target: $47 → $55
Current: $24.62
Upside: +123.40%
Nov 10, 2020
Initiates: Sector Weight
Price Target: n/a
Current: $33.85
Upside: -
Nov 10, 2020
Initiates: Sector Weight
Price Target: n/a
Current: $98.28
Upside: -
Oct 23, 2017
Upgrades: Neutral
Price Target: n/a
Current: $128.52
Upside: -